NCT03685591 2024-06-26PF-06952229 Treatment in Adult Patients With Advanced Solid TumorsPfizerPhase 1 Terminated49 enrolled 33 charts
NCT01234480 2023-05-16Intended Use Study of the BD SurePath Plusâ„¢ PapBecton, Dickinson and CompanyTerminated5,859 enrolled 4 charts
NCT02376699 2023-05-01Safety Study of SEA-CD40 in Cancer PatientsSeagen Inc.Phase 1 Terminated159 enrolled
NCT01142869 2017-05-08An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and NeckMerck KGaA, Darmstadt, GermanyTerminated133 enrolled
NCT00272181 2015-12-23Study of Proxinium for Treating Patients With Squamous Cell Head and Neck CancerSesen Bio, Inc.Phase 2 Terminated15 enrolled
NCT00412776 2015-12-23Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck CancerSesen Bio, Inc.Phase 2/3 Terminated165 enrolled